Ask
Search
My library
ORKG

We use cookies to provide a better user experience.

Data Protection

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.52.8
Backend: v1.14.2

Gariepy (corresponding author

Masayuki Arakawa
Tomoya Mita
Kosuke Azuma
Chie Ebato
Hiromasa Goto
Yoshio Fujitani
Takahisa Hirose
Ryuzo Kawamori
Tomoya Mita
Hirotaka Watada

Publication date

July 2015

Abstract

Exendin-4 and atherosclerogenesis Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-

Extracted data

Gariepy (corresponding author | ORKG Ask

Related items

Glucagon-like peptide-1 receptor controls exocytosis in chromaffin cells by increasing full-fusion events

Ayoze González-Santana
Judith Estévez-Herrera
Elizabeth P. Seward
Ricardo Borges
José David Machado

August 2021

Summary: Agonists for glucagon-like-peptide-1 receptor (GLP-1R) are currently used for the treatment...

A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site ofNODAGA as chelator

Jodal, Andreas
Lankat-Buttgereit, Brigitte
Brom, Maarten
Schibli, Roger
Behe, Martin

June 2014

Background Various diseases derive from pathologically altered β-cells. Their function can be incre...

Exendin-4 Increases Scavenger Receptor Class BI Expression via Activation of AMPK/FoxO1 in Human Vascular Endothelial Cells

Jingya Lyu
Hitomi Imachi
Kensaku Fukunaga
Seisuke Sato
Toshihiro Kobayashi
Takanobu Saheki
Salimah Japar
Hisakazu Iwama
Yuta Matsumura
Miyo Ozaki
Takafumi Yoshimura
Koji Murao

November 2022

Glucagon-like peptide-1 receptor agonist (GLP-1RA) has been clinically proven to protect endothelial...

Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like

Hirotaka Watada

August 2016

OBJECTIVE—Exogenous administration of glucagon-like pep-tide-1 (GLP-1) or GLP-1 receptor agonists su...

Correspondence to:

January 2008

Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosi

Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration

Wang, Y.
Parlevliet, E.T.
Geerling, J.J.
van der Tuin, S.J.
Zhang, H.
Bieghs, V.
Jawad, A.H.
Shiri-Sverdlov, R.
Bot, I.
de Jager, S.C.
Havekes, L.M.
Romijn, J.A.
van Dijk, K
Rensen, P.C.

February 2014

BACKGROUND AND PURPOSE: The aetiology of inflammation in the liver and vessel wall, leading to non-a...

Exendin-4 promotes endothelial barrier enhancement via PKA- and Epac1-dependent Rac1 activation

Li, Ai Q.
Zhao, Liang
Zhou, Teng F.
Zhang, Meng Q.
Qin, Xiao M.

January 2015

Among emerging antidiabetic agents, glucagon-like peptide-1 (GLP-1)-based therapies carry special ca...

Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.

Kosuke Nagayama
Yoji Kyotani
Jing Zhao
Satoyasu Ito
Kentaro Ozawa
Francesco A Bolstad
Masanori Yoshizumi

Angiotensin II (Ang II) is a main pathophysiological culprit peptide for hypertension and atheroscle...

Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner

Wei, Rui
Ma, Shifeng
Wang, Chen
Ke, Jing
Yang, Jin
Li, Weihong
Liu, Ye
Hou, Wenfang
Feng, Xinheng
Wang, Guang
Hong, Tianpei

January 2016

Glucagon-like peptide-1 (GLP-1) may have direct favorable effects on cardiovascular system. The aim ...

Exendin-4 improves cardiac function in mice overexpressing monocyte chemoattractant protein-1 in cardiomyocytes

January 2015

The incretin hormone glucagon-like peptide-1 (Glp1) is cardioprotective in models of ischemia-reperf...

Exendin-4 Improves Cardiac Function In Mice Overexpressing Monocyte Chemoattractant Protein-1 In Cardiomyocytes

Younce, Craig W.
Niu, Jianli
Ayala, Jennifer
Burmeister, Melissa A.
Smith, Layton H.

November 2014

The incretin hormone glucagon-like peptide-1 (Glp1) is cardioprotective in models of ischemia-reperf...

RESEARCH ARTICLE Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways

Kosuke Nagayama
Yoji Kyotani
Jing Zhao
Satoyasu Ito
Kentaro Ozawa
A. Bolstad
Masanori Yoshizumi

August 2016

Angiotensin II (Ang II) is a main pathophysiological culprit peptide for hypertension and ath-eroscl...

The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca(2+) signalling in steatotic hepatocytes

Ali, E.
Hua, J.
Wilson, C.
Tallis, G.
Zhou, F.
Rychkov, G.
Barritt, G.

January 2016

Available online 10 May 2016Abstract not availableEunüs S. Ali, Jin Hua, Claire H.Wilson, George A. ...

The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis

Panjwani, Naim

November 2013

Objective: Glucagon-like peptide-1 receptor (GLP-1R) agonists have been shown to reduce atherosclero...

Exendin-4はERK1/2とJNKの阻害を介してアンギオテンシンⅡによる血管平滑筋細胞の増殖と遊走を抑制する

Nagayama, Kosuke
Kyotani, Yoji
Zhao, Jing
Ito, Satoyasu
Ozawa, Kentaro
Bolstad, Francesco A.
Yoshizumi, Masanori

March 2016

Angiotensin II (Ang II) is a main pathophysiological culprit peptide for hypertension and atheroscle...

Glucagon-like peptide-1 receptor controls exocytosis in chromaffin cells by increasing full-fusion events

Ayoze González-Santana
Judith Estévez-Herrera
Elizabeth P. Seward
Ricardo Borges
José David Machado

August 2021

Summary: Agonists for glucagon-like-peptide-1 receptor (GLP-1R) are currently used for the treatment...

A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site ofNODAGA as chelator

Jodal, Andreas
Lankat-Buttgereit, Brigitte
Brom, Maarten
Schibli, Roger
Behe, Martin

June 2014

Background Various diseases derive from pathologically altered β-cells. Their function can be incre...

Exendin-4 Increases Scavenger Receptor Class BI Expression via Activation of AMPK/FoxO1 in Human Vascular Endothelial Cells

Jingya Lyu
Hitomi Imachi
Kensaku Fukunaga
Seisuke Sato
Toshihiro Kobayashi
Takanobu Saheki
Salimah Japar
Hisakazu Iwama
Yuta Matsumura
Miyo Ozaki
Takafumi Yoshimura
Koji Murao

November 2022

Glucagon-like peptide-1 receptor agonist (GLP-1RA) has been clinically proven to protect endothelial...

Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like

Hirotaka Watada

August 2016

OBJECTIVE—Exogenous administration of glucagon-like pep-tide-1 (GLP-1) or GLP-1 receptor agonists su...

Correspondence to:

January 2008

Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosi

Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration

Wang, Y.
Parlevliet, E.T.
Geerling, J.J.
van der Tuin, S.J.
Zhang, H.
Bieghs, V.
Jawad, A.H.
Shiri-Sverdlov, R.
Bot, I.
de Jager, S.C.
Havekes, L.M.
Romijn, J.A.
van Dijk, K
Rensen, P.C.

February 2014

BACKGROUND AND PURPOSE: The aetiology of inflammation in the liver and vessel wall, leading to non-a...

Exendin-4 promotes endothelial barrier enhancement via PKA- and Epac1-dependent Rac1 activation

Li, Ai Q.
Zhao, Liang
Zhou, Teng F.
Zhang, Meng Q.
Qin, Xiao M.

January 2015

Among emerging antidiabetic agents, glucagon-like peptide-1 (GLP-1)-based therapies carry special ca...

Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.

Kosuke Nagayama
Yoji Kyotani
Jing Zhao
Satoyasu Ito
Kentaro Ozawa
Francesco A Bolstad
Masanori Yoshizumi

Angiotensin II (Ang II) is a main pathophysiological culprit peptide for hypertension and atheroscle...

Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner

Wei, Rui
Ma, Shifeng
Wang, Chen
Ke, Jing
Yang, Jin
Li, Weihong
Liu, Ye
Hou, Wenfang
Feng, Xinheng
Wang, Guang
Hong, Tianpei

January 2016

Glucagon-like peptide-1 (GLP-1) may have direct favorable effects on cardiovascular system. The aim ...

Exendin-4 improves cardiac function in mice overexpressing monocyte chemoattractant protein-1 in cardiomyocytes

January 2015

The incretin hormone glucagon-like peptide-1 (Glp1) is cardioprotective in models of ischemia-reperf...

Exendin-4 Improves Cardiac Function In Mice Overexpressing Monocyte Chemoattractant Protein-1 In Cardiomyocytes

Younce, Craig W.
Niu, Jianli
Ayala, Jennifer
Burmeister, Melissa A.
Smith, Layton H.

November 2014

The incretin hormone glucagon-like peptide-1 (Glp1) is cardioprotective in models of ischemia-reperf...

RESEARCH ARTICLE Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways

Kosuke Nagayama
Yoji Kyotani
Jing Zhao
Satoyasu Ito
Kentaro Ozawa
A. Bolstad
Masanori Yoshizumi

August 2016

Angiotensin II (Ang II) is a main pathophysiological culprit peptide for hypertension and ath-eroscl...

The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca(2+) signalling in steatotic hepatocytes

Ali, E.
Hua, J.
Wilson, C.
Tallis, G.
Zhou, F.
Rychkov, G.
Barritt, G.

January 2016

Available online 10 May 2016Abstract not availableEunüs S. Ali, Jin Hua, Claire H.Wilson, George A. ...

The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis

Panjwani, Naim

November 2013

Objective: Glucagon-like peptide-1 receptor (GLP-1R) agonists have been shown to reduce atherosclero...

Exendin-4はERK1/2とJNKの阻害を介してアンギオテンシンⅡによる血管平滑筋細胞の増殖と遊走を抑制する

Nagayama, Kosuke
Kyotani, Yoji
Zhao, Jing
Ito, Satoyasu
Ozawa, Kentaro
Bolstad, Francesco A.
Yoshizumi, Masanori

March 2016

Angiotensin II (Ang II) is a main pathophysiological culprit peptide for hypertension and atheroscle...

Glucagon-like peptide-1 receptor controls exocytosis in chromaffin cells by increasing full-fusion events

Ayoze González-Santana
Judith Estévez-Herrera
Elizabeth P. Seward
Ricardo Borges
José David Machado

August 2021

Summary: Agonists for glucagon-like-peptide-1 receptor (GLP-1R) are currently used for the treatment...

A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site ofNODAGA as chelator

Jodal, Andreas
Lankat-Buttgereit, Brigitte
Brom, Maarten
Schibli, Roger
Behe, Martin

June 2014

Background Various diseases derive from pathologically altered β-cells. Their function can be incre...

Exendin-4 Increases Scavenger Receptor Class BI Expression via Activation of AMPK/FoxO1 in Human Vascular Endothelial Cells

Jingya Lyu
Hitomi Imachi
Kensaku Fukunaga
Seisuke Sato
Toshihiro Kobayashi
Takanobu Saheki
Salimah Japar
Hisakazu Iwama
Yuta Matsumura
Miyo Ozaki
Takafumi Yoshimura
Koji Murao

November 2022

Glucagon-like peptide-1 receptor agonist (GLP-1RA) has been clinically proven to protect endothelial...